Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Drug Safety Oversight Board May Include Advisory Committee Chairs

Executive Summary

FDA plans to appoint advisory committee chairmen to serve on its Drug Safety Oversight Board, Acting Commissioner Lester Crawford said Feb. 26 at the Generic Pharmaceutical Association annual meeting in Boca Raton, Fla

You may also be interested in...



FDA Names Drug Safety Board Members; First Meeting In Early Summer

Department of Veterans Affairs pharmacy benefit management advisor Chester Good brings experience with drug-related adverse event reporting to FDA's Drug Safety Oversight Board

FDA Names Drug Safety Board Members; First Meeting In Early Summer

Department of Veterans Affairs pharmacy benefit management advisor Chester Good brings experience with drug-related adverse event reporting to FDA's Drug Safety Oversight Board

Drug Safety Board Will Lead To More Advisory Cmte. Meetings – FDA’s Galson

The advent of FDA's Drug Safety Oversight Board will likely lead to an increase in the number of advisory committee meetings, Center for Drug Evaluation & Research Acting Director Steven Galson said at a meeting of FDA's Science Board April 15

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045467

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel